BR100 Increased By (0.2%)
BR30 Increased By (0.41%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.23%)
AGHA 7.75 Decreased By ▼ -0.17 (-2.15%)
BECO 5.19 Decreased By ▼ -0.01 (-0.19%)
BML 58.66 Decreased By ▼ -0.59 (-1%)
BOP 33.69 Increased By ▲ 0.01 (0.03%)
CNERGY 10.61 Increased By ▲ 0.80 (8.15%)
CSIL 5.30 Decreased By ▼ -0.12 (-2.21%)
FCCL 53.74 Increased By ▲ 0.22 (0.41%)
FFL 16.46 Decreased By ▼ -0.22 (-1.32%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 7.28 Decreased By ▼ -0.07 (-0.95%)
KOSM 5.64 Increased By ▲ 0.03 (0.53%)
LOTCHEM 29.65 Increased By ▲ 0.54 (1.86%)
MLCF 96.36 Increased By ▲ 0.86 (0.9%)
NBP 203.53 Decreased By ▼ -0.82 (-0.4%)
NCPL 56.85 Decreased By ▼ -1.39 (-2.39%)
NPL 67.31 Decreased By ▼ -0.48 (-0.71%)
OGDC 318.22 Increased By ▲ 0.28 (0.09%)
PACE 10.63 Decreased By ▼ -0.08 (-0.75%)
PAEL 41.77 Decreased By ▼ -0.06 (-0.14%)
PIBTL 16.81 Increased By ▲ 0.31 (1.88%)
PPL 220.17 Increased By ▲ 0.43 (0.2%)
PRL 49.05 Increased By ▲ 4.46 (10%)
PTC 70.01 Decreased By ▼ -0.76 (-1.07%)
SSGC 29.14 Increased By ▲ 0.21 (0.73%)
TBL 9.77 Decreased By ▼ -0.07 (-0.71%)
TELE 8.82 Increased By ▲ 0.06 (0.68%)
TPL 17.17 Increased By ▲ 0.72 (4.38%)
TPLP 12.51 Increased By ▲ 0.41 (3.39%)
TREET 22.59 Decreased By ▼ -0.21 (-0.92%)
TRG 60.22 Increased By ▲ 0.19 (0.32%)
By

THE HAGUE: Dutch electronics giant Philips said Wednesday it has set aside a further 225 million euros for a recall of faulty respiratory equipment that puts users at risk of inhaling toxic foam.

The company earmarked 500 million euros ($567 million) for the issue last year, but said more money was needed because more of the devices needed to be repaired than expected.

Philips shares fell 14 percent on the Amsterdam stock exchange after the announcement.

"Patient well-being is at the heart of everything we do at Philips, and we aim to get a solution to patients as fast as possible," Philips chief executive Frans van Houten said in a statement.

The devices in question are mainly for use in the home for patients with problems such as sleep apnoea, a disorder in which breathing stops and starts.

Philips recalled them in June after announcing that users were at risk of inhaling or swallowing pieces of degraded sound-dampening foam.

Philips Q4 earnings hit by part shortages and ventilator recall

Patients risked "possible toxic and carcinogenic effects" from the foam, as well as other symptoms including headaches, the firm said last year.

Philips said it was now "increasing the field action provision by around 225 million euros, mainly due to the higher volume of devices now requiring remediation", after expanding the recall to some older models.

The firm now expects to have to repair 5.2 million devices worldwide. So far it said it had produced 1.5 million repair kits of which 700,000 have reached customers.

Philips has confirmed it is a defendant in a number of consumer class action lawsuits from users of the devices as well as some personal injury claims.

It warned on Wednesday that sales for the final quarter of 2021 are likely to be 350 million euros lower than expected at 4.9 billion euros, due to the recall and supply chain problems.

Philips was founded as a lighting firm more than 100 years ago and made its name through household appliances but in recent years has focused on healthcare.

Comments

Comments are closed for this article.